Exchange: NASDAQ·Updated 07:59 PM EST

About MRKR

About

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
5

Frequently Asked Questions

Advertisement|Remove ads.